N
NewAmsterdam Pharma Company N.V. (NAMS)
NGM – Real vaqt narxi. Valyuta: USD
27.83
+0.21 (0.76%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
28.10
+0.27 (0.97%)
Bozordan keyin: Aug 12, 2026, 6:37 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
27.83
+0.21 (0.76%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
28.10
+0.27 (0.97%)
Bozordan keyin: Aug 12, 2026, 6:37 PM EDT
This stock has a consensus price target of $46.25 based on the ratings of 13 analysts. The high is $52.00 and the low is $37.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 37 | $ 46.25 | $ 52 |
| O’zgarish | 34.06% | 67.57% | 88.41% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-30 | 82.4% | RBC Capital | $47 → $51 | Maintains | Outperform |
| 2026-02-19 | 60.94% | Guggenheim | $41 → $45 | Maintains | Buy |
| 2026-02-18 | 71.67% | Needham | $46 → $48 | Maintains | Buy |
| 2026-01-21 | 68.1% | RBC Capital | $44 → $47 | Maintains | Outperform |
| 2025-12-16 | 78.83% | Stifel | $44 → $50 | Maintains | Buy |